Zobrazeno 1 - 10
of 236
pro vyhledávání: '"Trygve, Holmøy"'
Publikováno v:
Journal of Medical Case Reports, Vol 17, Iss 1, Pp 1-5 (2023)
Abstract Background Progressive encephalomyelitis with rigidity and myoclonus (PERM) is a rare neurological condition with paraneoplastic etiology in about 20% of cases, usually presenting before or shortly after the oncological diagnosis is establis
Externí odkaz:
https://doaj.org/article/213080ba48d64b1399c45285dc2f6f5b
Autor:
Lise Beier Havdal, Joel Selvakumar, Lise Lund Berven, Tonje Stiansen-Sonerud, Henrik Zetterberg, Kaj Blennow, Trygve Holmøy, Vegard Bruun Bratholm Wyller
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
IntroductionThe post-COVID-19 condition (PCC) is characterized by debilitating persistent symptoms, including symptoms suggesting neurological aberrations such as concentration difficulties, impaired memory, pain, and sleep disturbances. The underlyi
Externí odkaz:
https://doaj.org/article/139076211fd64154af8e2e03fb3c17cb
Publikováno v:
Brain, Behavior, & Immunity - Health, Vol 34, Iss , Pp 100704- (2023)
Background: T cell infiltration around dying motor neurons is a hallmark of amyotrophic lateral sclerosis (ALS). It is not known if this immune response represents a cause or a consequence of the disease. We aimed to establish whether individual vari
Externí odkaz:
https://doaj.org/article/bbfb14fa9c15465380da6ee686651a2a
Autor:
Asia-Sophia Wolf, Anthony Ravussin, Marton König, Mathias H. Øverås, Guri Solum, Ingrid Fadum Kjønstad, Adity Chopra, Trygve Holmøy, Hanne F. Harbo, Silje Watterdal Syversen, Kristin Kaasen Jørgensen, Einar August Høgestøl, Jon Torgils Vaage, Elisabeth G. Celius, Fridtjof Lund-Johansen, Ludvig A. Munthe, Gro Owren Nygaard, Siri Mjaaland
Publikováno v:
JCI Insight, Vol 8, Iss 12 (2023)
Immune responses in people with multiple sclerosis (pwMS) receiving disease-modifying therapies (DMTs) have been of significant interest throughout the COVID-19 pandemic. Lymphocyte-targeting immunotherapies, including anti-CD20 treatments and sphing
Externí odkaz:
https://doaj.org/article/5ba69269a3e644d2844eed3988e93d9c
Autor:
Klaus Thanke Aspli, Jan O. Aaseth, Trygve Holmøy, Kaj Blennow, Henrik Zetterberg, Bjørn-Eivind Kirsebom, Tormod Fladby, Per Selnes
Publikováno v:
Brain Sciences, Vol 13, Iss 11, p 1511 (2023)
Skogholt’s disease is a rare neurological disorder that is only observed in a small Norwegian kindred. It typically manifests in adulthood with uncharacteristic neurological symptoms from both the peripheral and central nervous systems. The etiolog
Externí odkaz:
https://doaj.org/article/008136d6590244e5aa5d5eafebecfc93
Publikováno v:
Case Reports in Genetics, Vol 2023 (2023)
Genetic variants in SPAST are the most common cause of hereditary spastic paraplegia (HSP), entitled spastic paraplegia type 4 (SPG4). Inheritance is autosomal dominant, and age of onset can vary from childhood to adulthood. Pathogenic SPAST variants
Externí odkaz:
https://doaj.org/article/19a297482c244e309abc0853c18232b8
Publikováno v:
BMJ Open, Vol 12, Iss 3 (2022)
Objective To evaluate the effect of a specific communication training for neurologists on how to provide complex information about treatment options to patients with multiple sclerosis (MS).Design Single-centre, single-blind, randomised controlled tr
Externí odkaz:
https://doaj.org/article/4a660338df42404d8574036721b701ad
Publikováno v:
BMC Research Notes, Vol 12, Iss 1, Pp 1-5 (2019)
Abstract Objective Sporadic fatal adverse events have been reported during treatment of multiple sclerosis with alemtuzumab. To provide a systematic overview, we searched the centralized European Medicines Agency database of suspected adverse reactio
Externí odkaz:
https://doaj.org/article/ada57fd7681243eb983f58d280c0ea78
Autor:
Rune A. Høglund, Robert D. Bremel, E. Jane Homan, Silje Bøen Torsetnes, Andreas Lossius, Trygve Holmøy
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
B cells are important pathogenic players in multiple sclerosis (MS), but their exact role is not known. We have previously demonstrated that B cells from cerebrospinal fluid (CSF) of MS patients can activate T cells that specifically recognize antige
Externí odkaz:
https://doaj.org/article/ad9de4d33e9049f18ac6b5da39f786da
Autor:
Egil Røsjø, Jonas C. Lindstrøm, Trygve Holmøy, Kjell-Morten Myhr, Kristin N. Varhaug, Øivind Torkildsen
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Background: High serum levels of 25-hydroxyvitamin D (25(OH)D) have been found among patients with a favorable disease course in relapsing-remitting MS (RRMS), indicating that this may limit clinical deterioration. Clinical deterioration in RRMS corr
Externí odkaz:
https://doaj.org/article/2ae157a7eedb48a681bffc817a96ef73